Progressive Multifocal Leukoencephalopathy [version 1; referees: 2 approved]

Progressive Multifocal Leukoencephalopathy [version 1; referees: 2 approved]

Progressive multifocal leukoencephalopathy (PML) is a devastating demyelinating disease with significant morbidity and mortality and no effective, targeted therapies. It is most often observed in association with abnormalities of cell-mediated immunity, in particular human immunodeficiency virus (HI...

Full description

Bibliographic Details
Main Authors:	Laura Adang, Joseph Berger
Format:	Article
Language:	English
Published:	F1000 Research Ltd 2015-12-01
Series:	F1000Research
Subjects:	HIV Infection & AIDS: Clinical Infectious Diseases of the Nervous System Multiple Sclerosis & Related Disorders Neuroimaging Viral Infections (without HIV)
Online Access:	http://f1000research.com/articles/4-1424/v1

Similar Items

Understanding the association between chromosomally integrated human herpesvirus 6 and HIV disease: a cross-sectional study [version 2; referees: 2 approved, 1 approved with reservations]
by: Mundeep K. Kainth, et al.
Published: (2017-06-01)

Human metapneumovirus - what we know now [version 1; referees: 2 approved]
by: Nazly Shafagati, et al.
Published: (2018-02-01)

Miltefosine inhibits Chikungunya virus replication in human primary dermal fibroblasts [version 1; referees: 2 approved, 1 approved with reservations]
by: Anuj Sharma, et al.
Published: (2018-01-01)

Cardiovascular involvement and manifestations of systemic Chikungunya virus infection: A systematic review [version 1; referees: 1 approved, 2 approved with reservations]
by: María Fernanda Alvarez, et al.
Published: (2017-03-01)

Cardiovascular involvement and manifestations of systemic Chikungunya virus infection: A systematic review [version 2; referees: 1 approved, 2 approved with reservations]
by: María Fernanda Alvarez, et al.
Published: (2017-05-01)

Enterovirus D68 in Viet Nam (2009-2015) [version 1; referees: 2 approved, 1 approved with reservations]
by: Nguyen Thi Han Ny, et al.
Published: (2017-06-01)

ve-SEQ: Robust, unbiased enrichment for streamlined detection and whole-genome sequencing of HCV and other highly diverse pathogens [version 1; referees: 2 approved]
by: David Bonsall, et al.
Published: (2015-10-01)

The immunology of Zika Virus [version 1; referees: 2 approved]
by: Abigail Culshaw, et al.
Published: (2018-02-01)

Antigenicity of peptides comprising the immunosuppressive domain of the retroviral envelope glycoprotein [version 2; referees: 2 approved]
by: Bryony Jenkins, et al.
Published: (2017-02-01)

Antigenicity of peptides comprising the immunosuppressive domain of the retroviral envelope glycoprotein [version 1; referees: 2 approved]
by: Bryony Jenkins, et al.
Published: (2016-12-01)

In silico analysis of natural compounds targeting structural and nonstructural proteins of chikungunya virus [version 2; referees: 2 approved]
by: Jaspreet Jain, et al.
Published: (2017-12-01)

Impact of IL-27 on hepatocyte antiviral gene expression and function [version 1; referees: 1 approved, 2 approved with reservations]
by: Narayan Ramamurthy, et al.
Published: (2016-11-01)

Current Landscape of Antiviral Drug Discovery [version 1; referees: 2 approved]
by: Wade Blair, et al.
Published: (2016-02-01)

A new panel of epitope mapped monoclonal antibodies recognising the prototypical tetraspanin CD81 [version 1; referees: 1 approved, 2 approved with reservations]
by: Joe Grove, et al.
Published: (2017-09-01)

Zika antiviral chemotherapy: identification of drugs and promising starting points for drug discovery from an FDA-approved library [version 1; referees: 2 approved]
by: Bruno S. Pascoalino, et al.
Published: (2016-10-01)

Case Report: Postpartum hemorrhage associated with Dengue with warning signs in a term pregnancy and delivery [version 1; referees: 2 approved, 1 not approved]
by: Le Phi Hung, et al.
Published: (2015-12-01)

Human papillomavirus vaccination: the population impact [version 1; referees: 3 approved]
by: Lai-yang Lee, et al.
Published: (2017-06-01)

Machine learning models identify molecules active against the Ebola virus in vitro [version 3; referees: 2 approved]
by: Sean Ekins, et al.
Published: (2017-01-01)

Machine learning models identify molecules active against the Ebola virus in vitro [version 1; referees: 2 approved]
by: Sean Ekins, et al.
Published: (2015-10-01)

Machine learning models identify molecules active against the Ebola virus in vitro [version 2; referees: 2 approved]
by: Sean Ekins, et al.
Published: (2016-01-01)

Lyssaviruses and rabies: current conundrums, concerns, contradictions and controversies [version 1; referees: 2 approved]
by: Charles Rupprecht, et al.
Published: (2017-02-01)

Cerebrospinal Fluid Biomarkers of Japanese Encephalitis [v2; ref status: indexed, http://f1000r.es/5uq]
by: Nabonita Sengupta, et al.
Published: (2015-09-01)

Kyasanur forest disease virus: viremia and challenge studies in monkeys with evidence of cross-protection by Langat virus infection [v1; ref status: indexed, http://f1000r.es/UiWGcy]
by: Keerti V Shah, et al.
Published: (2012-12-01)

Evidence synthesis and decision modelling to support complex decisions: stockpiling neuraminidase inhibitors for pandemic influenza usage [version 2; referees: 2 approved]
by: Samuel I. Watson, et al.
Published: (2017-03-01)

Current strategies to treat tuberculosis [version 1; referees: 2 approved]
by: Anthony T. Podany, et al.
Published: (2016-10-01)

Chikungunya: epidemiology [version 1; referees: 2 approved]
by: Lyle R. Petersen, et al.
Published: (2016-01-01)

Management of children with prolonged diarrhea [version 1; referees: 3 approved]
by: Antonietta Giannattasio, et al.
Published: (2016-02-01)

Some vexations that challenge viral immunology [version 1; referees: 2 approved]
by: Barry T. Rouse, et al.
Published: (2016-05-01)

Misleading hepatitis B testing in the setting of intravenous immunoglobulin [v1; ref status: indexed, http://f1000r.es/25r]
by: Christelle M Ilboudo, et al.
Published: (2013-11-01)

Recent advances in understanding dengue [version 1; referees: 3 approved]
by: Sophie Yacoub, et al.
Published: (2016-01-01)

Efficacy of an 8-week course of sofosbuvir and ledipasvir for the treatment of HCV infection in selected HIV-infected patients [version 2; referees: 2 approved]
by: Onyema Ogbuagu, et al.
Published: (2018-09-01)

HIV-associated neurocognitive disorders: recent advances in pathogenesis, biomarkers, and treatment [version 1; referees: 4 approved]
by: Antonia Carroll, et al.
Published: (2017-03-01)

Cerebrospinal fluid analysis in 108 patients with progressive multifocal leukoencephalopathy
by: Nora Möhn, et al.
Published: (2020-10-01)

Novel approaches to HIV therapy [version 1; referees: 2 approved]
by: Eric S. Daar
Published: (2017-05-01)

Recent advances in understanding noroviruses [version 1; referees: 2 approved]
by: Eric Bartnicki, et al.
Published: (2017-01-01)

Identification of Molecular Mechanisms Involved in Viral Infection Progression Based on Text Mining: Case Study for HIV Infection
by: Olga Tarasova, et al.
Published: (2023-01-01)

Advances in understanding COPD [version 1; referees: 3 approved]
by: Gary P. Anderson
Published: (2016-09-01)

Recent advances in managing hepatitis D [version 1; referees: 2 approved]
by: Cihan Yurdaydin
Published: (2017-08-01)

Incorporating health workers’ perspectives into a WHO guideline on personal protective equipment developed during an Ebola virus disease outbreak [version 1; referees: 2 approved]
by: Saskia Den Boon, et al.
Published: (2018-01-01)

Incorporating health workers’ perspectives into a WHO guideline on personal protective equipment developed during an Ebola virus disease outbreak [version 2; referees: 2 approved]
by: Saskia Den Boon, et al.
Published: (2018-03-01)